Mexican millions for Saniona
Danish biotech company Saniona has signed a development and commercialization deal with a Mexican company, which will initially give the Danes a million-dollar cash injection and could lead to greater opportunities in Latin America in the long run.
BY STEFAN SINGH KAILAY
Denmark-based biotech company Saniona has moved one step closer to regulatory approval of a drug to treat obesity through an agreement that will save the company some expenses in the process.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Saniona signs million-dollar deal with US-based company
For abonnenter
Pfizer cancels partnership with Danish biotech
For abonnenter
Biotech initiates partnership search immediately
For abonnenter
